Elizabeth Murphy Lilly - Jun 20, 2024 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role
Director
Signature
/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Stock symbol
APOG
Transactions as of
Jun 20, 2024
Transactions value $
$0
Form type
4
Date filed
6/21/2024, 04:55 PM
Previous filing
Apr 1, 2024
Next filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APOG Deferred Restricted Stock Units Award $0 +1.89K +103.33% $0.00 3.73K Jun 20, 2024 Common Stock 1.89K $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.
F2 Settled 1-for-1.
F3 Includes deferred restricted stock units acquired pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.